1. Choi J, Kim SH, Ahn SS, et al. Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma. Scientific reports. 2020;10(1):2086.

2. Park SH, Choi WH, Choi J. Fetal dose from Head and Neck Tomotherapy Versus 3D Conformal Radiotherapy. Journal of Radiation Protection and Research. 2019; 44(4): 156-160.

3. Kim JW, Cho Y, Choi J, Ahn SG, Jeong J, Lee IJ. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment. Annals of surgical oncology. 2019;26(13):4294-4301.

4. Yang AJ, Choi SH, Byun HK, et al. Management of Clinical T1N0M0 Esophageal Cancer. Gut and liver. 2019;13(3):315-324

5. Choi J, Lee EJ, Yang SH, Im YR, Seong J. A prospective Phase II study for the efficacy of radiotherapy in combination with zoledronic acid in treating painful bone metastases from gastrointestinal cancers. Journal of radiation research. 2019;60(2):242-248

6. Choi J, Kim JW, Jeon TJ, Lee IJ. The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes. PloS one. 2018;13(9):e0204918.

7. Choi SH, Chang JS, Choi J, et al. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer. Anticancer research. 2018;38(5):3165-3173.

8. Choi SH, Kim JW, Choi J, et al. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective. Clinical breast cancer. 2018;18(2):e167-e178.

9. Kim Y, Park HC, Yoon SM, et al. Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02). Oncotarget.2017;8(55):94450-94461.

10. Lee JJB, Choi J, Ahn SG, et al. In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost. Radiation oncology journal. 2017;35(2):121-128.

11. Rim CH, Choi C, Choi J, Seong J. Establishment of a Disease-Specific Graded Prognostic Assessment for Hepatocellular Carcinoma Patients with Spinal Metastasis. Gut and liver. 2017;11(4):535-542.

12. Yoon HI, Yoon J, Chung Y, et al. Individual case review in a phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer: Korean Radiation Oncology Group 08-06 study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2017;123(1):15-21.

13. Park K, Park S, Jeon MJ, et al. Clinical application of 3D-printed-step-bolus in post-total-mastectomy electron conformal therapy. Oncotarget. 2017;8(15):25660-25668.

14. Choi J, Kim SH, Koh YW, Choi EC, Lee CG, Keum KC. Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma. Cancer research and treatment : official journal of Korean Cancer Association. 2017;49(1):178-184.

15. Choi J, Kim YB, Shin KH, et al. Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study. Journal of breast cancer. 2016;19(3):275-282.

16. Choi J, Kim JW, Keum YS, Lee IJ. The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups. PloS one. 2016;11(4):e0154739.

17. Choi J, Yoon HI, Lee J, Keum KC, Kim GE, Kim YB. Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer.PloS one. 2015;10(12):e0145158.

18. Lee J, Lee J, Choi J, Kim JW, Cho J, Lee CG. Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer. Radiation oncology journal. 2015;33(2):117-125.

19. Kim Y, Hong SE, Kong M, Choi J. Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy. Cancer research and treatment : official journal of Korean Cancer Association. 2013;45(4):295-302.

20. Lee J, Choi J, Choi C, Seong J. Role of radiotherapy for pancreatobiliary neuroendocrine tumors. Radiation oncology journal. 2013;31(3):125-130.

21. Kong M, Hong SE, Choi WS, Choi J, Kim Y. Treatment outcomes of helical intensity-modulated radiotherapy for unresectable hepatocellular carcinoma. Gut and liver. 2013;7(3):343-351.

22. Kong M, Hong SE, Choi J, Kim Y. Comparison of survival rates between patients treated with conventional radiotherapy and helical tomotherapy for head and neck cancer. Radiation oncology journal. 2013;31(1):1-11.

23. Choi J, Kang JO. Basics of particle therapy II: relative biological effectiveness. Radiation oncology journal. 2012;30(1):1-13.

24. Kong M, Hong SE, Choi WS, Kim SY, Choi J. Preoperative concurrent chemoradiotherapy for locally advanced rectal cancer: treatment outcomes and analysis of prognostic factors. Cancer research and treatment : official journal of Korean Cancer Association. 2012;44(2):104-112.

25. Choi J, Kang JO, Park SH, Kim SK. Co-authorship patterns and networks of Korean radiation oncologists. Radiation oncology journal. 2011;29(3):164-173.

26. Kong M, Kang JO, Choi J, Park SH. A long term results of external beam radiation therapy in hemophilic arthropathy of the ankle in children. Journal of Korean medical science. 2010;25(12):1742-1747.